Kizilirmak, P. Et Al. 2022. Main Outcomes of the DIYAL-TR Study: Regional Differences of Mortality and Morbidity in Chronic Hemodialysis Patients. TURKISH JOURNAL OF NEPHROLOGY , vol.31, no.2 , 116-127.

Kizilirmak, P., Ecder, T., ATEŞ, K., ARICI, M., Sezer, S., Kaptanogullari, H., ... Arinsoy, T.(2022). Main Outcomes of the DIYAL-TR Study: Regional Differences of Mortality and Morbidity in Chronic Hemodialysis Patients. TURKISH JOURNAL OF NEPHROLOGY , vol.31, no.2, 116-127.

Kizilirmak, Pinar Et Al. "Main Outcomes of the DIYAL-TR Study: Regional Differences of Mortality and Morbidity in Chronic Hemodialysis Patients," TURKISH JOURNAL OF NEPHROLOGY , vol.31, no.2, 116-127, 2022

Kizilirmak, Pinar Et Al. "Main Outcomes of the DIYAL-TR Study: Regional Differences of Mortality and Morbidity in Chronic Hemodialysis Patients." TURKISH JOURNAL OF NEPHROLOGY , vol.31, no.2, pp.116-127, 2022

Kizilirmak, P. Et Al. (2022) . "Main Outcomes of the DIYAL-TR Study: Regional Differences of Mortality and Morbidity in Chronic Hemodialysis Patients." TURKISH JOURNAL OF NEPHROLOGY , vol.31, no.2, pp.116-127.

@article{article, author={Pinar Kizilirmak Et Al. }, title={Main Outcomes of the DIYAL-TR Study: Regional Differences of Mortality and Morbidity in Chronic Hemodialysis Patients}, journal={TURKISH JOURNAL OF NEPHROLOGY}, year=2022, pages={116-127} }